Back

Hepatic steatosis and incident cardiovascular events in patients with new-onset atrial fibrillation

29 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: New-onset atrial fibrillation: risk prediction, clinical management, and outcomes Prevalence and Incidence of Atrial Fibrillation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Sangho Sohn

Korea University Guro Hospital, Seoul (Korea (Republic of))

6 More presentations in this session

Presentation thumbnail
Ethnic differences in new-onset atrial fibrillation using multidimensional data
Doctor H. Naderi (London, GB)
Abstract
Presentation thumbnail
Beta-blockers vs amiodarone in management of new onset atrial fibrillation in patients receiving critical care services: an analysis from a global federated research network
Doctor K. Ahmadzadeh (Liverpool, GB)
Abstract
Presentation thumbnail
Predicting new-onset atrial fibrillation after transcatheter aortic valve implantation using the FIND-AF machine learning algorithm
Doctor J. Tan (Leeds, GB)
Abstract
Presentation thumbnail
Shifting clinical landscape of wild-type transthyretin amyloid cardiomyopathy: earlier detection, milder cardiac involvement, and reduced new-onset of atrial fibrillation in the contemporary era
Doctor H. Kondo (Yufu City, JP)
Abstract
Presentation thumbnail
Development and external validation of a pre-operative prediction model for new-onset atrial fibrillation after coronary artery bypass grafting
Miss W. Li (Exeter, GB)
Abstract

Access the full session

Session thumbnail
New-onset atrial fibrillation: risk prediction, clinical management, and outcomes

The Event

Event poster

ESC Congress 2026

29 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Liver steatosis, metabolically healthy obesity and ten-year cardiovascular disease risk: results from a population based cohort study.
28 August 2021
thumbnail
Congress Presentation
Heart failure in patients with and without new-onset atrial fibrillation in the context of acute coronary syndrome
23 May 2023
thumbnail
Congress Presentation
Epicardial adipose tissue and its association with atrial fibrillation in middle-aged patients without overt heart disease
10 May 2023
thumbnail
Congress Presentation
The association between dyslipidaemia treatment and the risk of clinical events in edoxaban-treated patients with atrial fibrillation: insights from the 2-year follow-up of ETNA-AF-Europe
28 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources